openPR Logo
Press release

Pre & Post COVID-19 Impact Analysis on Global radiopharmaceuticals Market to Show Tremendous Growth by 2027 | Leading Players-Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG

05-30-2020 10:49 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global radiopharmaceuticals market

Global radiopharmaceuticals market

A complete discussion about numerous market related topics in this Global radiopharmaceuticals market research report is sure to aid the client in studying the market on competitive landscape. This market analysis offers an examination of a range of segments that are relied upon to witness the quickest development amid the estimate forecast frame. The company profiles of all the key players and brands that are dominating the Global radiopharmaceuticals market with moves like product launches, joint ventures, mergers and acquisitions which in turn is affecting the sales, import, export, revenue and CAGR values are mentioned in the report. This report also gives you an idea about consumer's demands, preferences, and their altering likings about particular product.

The Global radiopharmaceuticals market report estimates 2018 - 2025 market development trends for industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also performed here. The report analyses some of the challenges that industry may have to face during the growth. This report also discusses about what technologies need to be worked on in order to incentivize future growth, the effects they will have on the market, and how they can be used. Furthermore, Global radiopharmaceuticals market research report also provides a watchful investigation of the current state of the market which covers several market dynamics.

The global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026. In the rise in market can be attributed to increasing prevalence of cancer and cardiovascular chronic diseases, rising health expenditure and technological advancements.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market

Global radiopharmaceuticals market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of radiopharmaceuticals for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Radiopharmaceuticals Market

Few of the major market competitors currently working in the radiopharmaceuticals market are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company., Jubilant Pharma. LLC, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Areva Pharma, Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, Curium, among others.

Key Developments in the Market:

In April 2018, Cyclopharma has entered into an agreement to sell all its radiopharmaceutical manufacturing and commercialization activities to Curium. With this acquisition, Curium would be able to expand its manufacturing, development and designs of new compounds, thereby expanding its radiopharmaceutical business to soon become a world leader
In January 2018, Advanced Accelerator Application (AAA) received the permission from USA's FDA to use Lutathera for treating a type of cancer which affects pancreas/ gastrointestinal tract i.e. Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This is the very first time approval has been given to use a radiopharmaceutical for treating GEP-NETs. Thus, with this approval, radiopharmaceuticals have now been approved to treat a whole new disease, thereby expanding its market, which would significantly contribute towards the growth of radiopharmaceuticals market globally in the forecasted period

Market Definition: Global Radiopharmaceuticals Market

Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiopharmaceuticals-market

Market Drivers

Increasing prevalence of cancer and cardiovascular chronic diseases, which is creating need for early diagnosis and treatment
Rising healthcare expenditure boosts the growth of this market
Growing awareness about the benefits of radiopharmaceuticals amongst healthcare providers also expands the growth of this market
Technological advancements an developments which allows the use of radio-labeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors
Increasing preference of SPECT and PET scans and growing preference of disease targeted cancer therapy

Market Restraints

Stringent regulatory guidelines and high cost of devices using radioisotopes
Short half-life of radiopharmaceutical

Get Free Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market

Reasons to Purchase this Report

Current and future of global radiopharmaceuticals market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.?

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pre & Post COVID-19 Impact Analysis on Global radiopharmaceuticals Market to Show Tremendous Growth by 2027 | Leading Players-Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG here

News-ID: 2062557 • Views: 364

More Releases from Data Bridge Market Research

Global Tamiflu (Oseltamivir Phosphate) Drugs Market Worldwide Business Growth An …
Global Tamiflu (oseltamivir phosphate) drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. This Tamiflu (oseltamivir phosphate) drugs market research report is one of the unsurpassed
Global Peptide Antibiotics Market To See Tremendous Growth | Leading Players Are …
Peptide antibiotics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the infectious diseases worldwide and recently approval of the drug are the factors responsible for the growth of this market. This Peptide antibiotics market research report is one of the unsurpassed and
Global Tumor Lysis Syndrome Market 2020:Size, Industry Status and Growth opportu …
Global tumor lysis syndrome market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. The growth in this market can be attributed to factors such as development of innovative therapies. Few of the major competitors currently working in the global tumor lysis syndrome market areSanofi, The Menarini Group, Merck KGaA, Takeda Pharmaceutical Company Limited,
Global Proctitis Market 2020:Current Trends and Technology Enhancements with Top …
Proctitis market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the inflammatory diseases worldwide and emerging markets are the factors responsible for the growth of this market. The statistical and numerical data collected to generate this credible market report is mostly denoted with

All 5 Releases


More Releases for Radiopharmaceuticals

Global Radiopharmaceuticals Market Outlook 2020 Report
“Global Radiopharmaceuticals Market Outlook 2020” Report Highlight: * Global Radiopharmaceutical Market Overview * Global Radiopharmaceuticals Market Dynamics * FDA & EMA Guidelines for Radiopharmaceuticals * Global Radiopharmaceuticals Clinical Pipeline Insight by Company, Indication & Phase * Global Radiopharmaceuticals Clinical Pipeline: 133 Radiopharmaceuticals * Majority Radiopharmaceuticals in Preclinical Phase: 44 Radiopharmaceuticals * Marketed Radiopharmaceuticals: 19 Radiopharmaceuticals Download Report Sample Weblink: https://www.kuickresearch.com/report-Global-Radiopharmaceuticals-Market-Outlook-2020.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario
Radiopharmaceuticals Market Estimated to Flourish by 2026
Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a